MA 02.10 Phase I Study of ABBV-399 (Telisotuzumab Vedotin)...

Journal of Thoracic Oncology 2017 / 11 Vol. 12; Iss. 11

MA 02.10 Phase I Study of ABBV-399 (Telisotuzumab Vedotin) as Monotherapy and in Combination with Erlotinib in NSCLC

Goldman, J., Angevin, E., Strickler, J., Camidge, D.R., Heist, R., Morgensztern, D., Barve, M., Yue, H., Beaulieu, J., Motwani, M., Afar, D., Naumovski, L., Kelly, K.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
12
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2017.09.458
Date:
November, 2017
File:
PDF, 370 KB
english, 2017
Conversion to is in progress
Conversion to is failed